Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of AZD1981 added to inhaled corticosteroid and long-acting beta2-agonist therapy in asthma
2010-020407-73Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of timapiprant in asthma (7 arms), sponsored by AstraZeneca. Primary endpoint: Pre-dose pre-bronchodilator FEV1. Started Jun 2010; status: completed.
02
Drugs
timapiprant
03
Conditions
asthma
Beyond the preview
Go deeper on 2010-020407-73.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020407-73.